IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IRADIMED CORPORATION on June 7, 2024, covering events reported as of June 5, 2024. The Company is a Delaware corporation with its principal executive offices in Winter Springs, FL. Its common stock trades under the symbol "IRMD" on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Listing Transfer: On June 5, 2024, the Company received approval from Nasdaq to transfer its common stock listing from the Nasdaq Capital Market to the Nasdaq Global Market.
- Effective Date: The transfer is effective as of the open of business on June 14, 2024.
- Trading Symbol: The stock will continue to trade under the symbol "IRMD".
Outlook, Risks, and Management Commentary
Management confirmed via a press release (Exhibit 99.1) that the uplisting to the Nasdaq Global Market will proceed as scheduled. The filing notes that the Nasdaq Global Market operates in substantially the same manner as the Capital Market, though listed companies must meet specific financial and corporate governance requirements. No new risks, contingencies, or unusual items were disclosed in this filing.
Investor Verification Checklist
- Verify the effective date of the listing transfer (June 14, 2024).
- Confirm the continued use of the "IRMD" trading symbol post-transfer.
- Review the attached press release (Exhibit 99.1) for additional details on the uplisting rationale.
- Check subsequent filings for any financial metrics required to maintain the Nasdaq Global Market listing standards.